The Woolcock Institute of Medical Research in Glebe, Sydney is offering a FREE full day symposium on Saturday 24 September 2016. World renowned Woolcock researchers and clinical experts will cover the key recommendations for recognising, diagnosing and managing patients with asthma and Chronic Obstructive Pulmonary Disease (COPD).
Poor asthma control is a common problem in both adults and children. Reddel et al.’s study, Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population has identified there are substantial problems with respect to prescribing and use of medications which challenges the perception that asthma is a “solved” problem in Australia, a view that may contribute to lack of attention to asthma in clinical practice.
Leader of the study, Woolcock Institute Research Leader and Physician, Associate Professor Helen Reddel, said the figures were alarming. “Asthma’s one of the most common chronic diseases, that affects one in 10 Australians. This study shows that for 45% it’s interfering with their daily life – symptoms that might send them into hospital.”
Woolcock Institute’s Research Leader and Physician, Associate Professor Greg King, reiterates these findings, “We need to increase awareness of both patients and healthcare professionals to the fact that asthma is still not optimally controlled. This is because with good assessment and a well thought out treatment plan that suits the individual, the vast majority of patients can expect to be free of asthma symptoms and its complications.”
Furthermore, a report by ACAM has found the most effective medications for managing asthma, COPD and other obstructive airways diseases are under-used in Australia. The report Respiratory medication use in Australia 2003-2013: treatment of asthma and COPD, shows that prescription medications were dispensed to over 2 million people in Australia (about 9% of the population) in 2013, but that most people only used them occasionally.
Our education program aims to support healthcare professionals by providing key recommendations in recognising, diagnosing, and managing patients with asthma and COPD based on our world renowned research and clinical expertise.
About this course:
This category 2 activity has been approved by the RACGP QI&CPD Program.
Total Points: 14 CPD points. Activity Number: 57844.
When: Saturday, 24 September 2016
Location: Woolcock Institute of Medical Research - 431 Glebe Point Road, Glebe NSW 2037
General Admission: This symposium will be held from 9am to 5.30pm
Webinar: Can't make it to Glebe on Saturday, 24 September 2016? Watch our live webinar.
Cost: FREE. Lunch provided.
This educational activity is supported by an independent educational grant from GlaxoSmithKline Australia.
We will also be hosting a sleep education day for healthcare professionals Saturday 26 November 2016. Click here to find out more.